TRUB1 is a novel biomarker for promoting malignancy in colorectal cancer via NFκB signaling
TRUB1 serves as a potential biomarker for CRC diagnosis and prognosis, and it can inhibit apoptosis in CRC cells via BIRC3-mediated NFκB signaling.
Authors
- Tian-hao Zhang (ORCID: https://orcid.org/0000-0002-4422-5581)
- Yonghuang Tan
- Jinping Ma (ORCID: https://orcid.org/0009-0000-0514-5039)
- Yingzhao Wang (ORCID: https://orcid.org/0009-0008-9103-8501)
- Zhenshuang Du
- Mei Yong
- Zhaoliang Wang (ORCID: https://orcid.org/0000-0001-5899-5395)
- Jingru Gong
Institutions
- Sun Yat-sen University (CN)
- Xiamen University (CN)
- Affiliated Hospital of Guizhou Medical University (CN)
- The First Affiliated Hospital, Sun Yat-sen University (CN)
- Southern Medical University (CN)
Publication Details
- Journal
- Gastroenterology report
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/gastro/goaf027
- Citations
- 1
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Guangzhou Municipal Science and Technology Project